
|Articles|June 26, 2016
High-Cost Branded Drug Prescribing Trend Highlights AJPB Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Common Virus May Hold New Clues to Lupus
2
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
3
Managing Safety and Supportive Care With Pluvicto: Insights From the PSMAddition Trial
4
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
5

















































































































































































































